Delegates from the member boards of pharmacy adopted six resolutions during the 117th NABP Annual Meeting, held virtually on May 13-14, 2021. The resolutions addressed pandemic-related issues, drug importation, and pharmacist workplace conditions, and more.
Delegates to the 117th NABP Annual Meeting, held virtually on May 13-14, 2021, elected individuals to fill the president-elect, treasurer, and open member positions on the Association’s 2021-2022 Executive Committee.
The newly elected officers of the NABP Executive Committee are:
• President-elect Reginald B. “Reggie” Dilliard, DPh;
• Treasurer Lenora S. Newsome, PD;
• Member Deborah C. Mack, RPh, CHC, CCEP, three-year term (District 6); and
• Member Nicole L. Chopski, PharmD, BCGP, ANP, second three-year term (District 7).
The following NABP Executive Committee officers and members are continuing to fulfill their terms:
• NABP President Caroline D. Juran, BSPharm, DPh (Hon), who assumed the office after serving a one-year term as NABP president-elect;
• Chairperson Timothy D. Fensky, RPh, DPh, FACA, who assumed the position after serving one-year terms as president and president-elect;
• Member Bradley S. Hamilton, RPh (District 1);
• Member Tejal J. Patel, MBA, PharmD, RPh (District 2);
• Member Jeffrey J. Mesaros, PharmD, JD, RPh (District 3);
• Member Fred M. Weaver, RPh, (District 4);
• Member Shane R. Wendel, PharmD, RPh (District 5); and
• Member Kamlesh “Kam” Gandhi, PharmD, RPh (District 8).
This post is related to:
Accreditation, Certification, Compliance